| Patent | Date |
|---|
Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
Grant 8,088,799 - Linz , et al. January 3, 2 | 2012-01-03 |
Use Of Urate Oxidase For The Treatment Or Prophylaxis Of Disorders Or Indirect Sequelae Of The Heart Caused By Ischemic Or Reperfusion Events
App 20100266567 - LINZ; Wolfgang ; et al. | 2010-10-21 |
Use of PPAR agonists for the treatment of congestive heart failure
Grant 7,601,863 - Linz , et al. October 13, 2 | 2009-10-13 |
Use Of Inhibitors Of The Cellular Na+/h+ Exchanger (nhe) For Preparing A Medicament For Normalizing Serum Lipids
App 20090143473 - LANG; Hans Jochen ; et al. | 2009-06-04 |
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
Grant 7,514,423 - Schafer , et al. April 7, 2 | 2009-04-07 |
Use Of Ppar Agonists For The Treatment Of Congestive Heart Failure
App 20080039512 - Linz; Wolfgang ; et al. | 2008-02-14 |
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
Grant 6,930,103 - Schafer , et al. August 16, 2 | 2005-08-16 |
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
App 20050171090 - Schafer, Stefan ; et al. | 2005-08-04 |
Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
Grant 6,844,361 - Linz , et al. January 18, 2 | 2005-01-18 |
Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
App 20050009899 - Linz, Wolfgang ; et al. | 2005-01-13 |
Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipids
App 20040122096 - Lang, Hans Jochen ; et al. | 2004-06-24 |
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
App 20040058911 - Schafer, Stefan ; et al. | 2004-03-25 |
Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
App 20030158247 - Linz, Wolfgang ; et al. | 2003-08-21 |
Mercaptoacetylamide derivatives, a process for their preparation and their use
Grant 6,602,866 - Flynn , et al. August 5, 2 | 2003-08-05 |
Mercaptoacetylamide derivatives, a process for their preparation and their use
App 20020193589 - Flynn, Gary A. ; et al. | 2002-12-19 |
Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart
Grant 6,462,024 - Lang , et al. October 8, 2 | 2002-10-08 |
Use of inhibitors of the sodium-hydrogen exchanger for preparing a medicament for preventing age-related disorders, and for prolonging life
Grant 6,420,430 - Linz , et al. July 16, 2 | 2002-07-16 |
Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals
App 20020058838 - Englert, Heinrich ; et al. | 2002-05-16 |
Substituted benzenesulfonylureas and thioureas-process for their preparation and their use as pharmaceuticals
Grant 6,335,467 - Englert , et al. January 1, 2 | 2002-01-01 |
Substituted benzenesulfonylureas and -thioureas--process for their preparation and their use as pharmaceuticals
Grant 6,090,981 - Englert , et al. July 18, 2 | 2000-07-18 |
3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
Grant 5,849,755 - Englert , et al. December 15, 1 | 1998-12-15 |
Substituted benzenesulfonylureas and thioureas process for their preparation and their use as pharmaceuticals
Grant 5,698,596 - Englert , et al. December 16, 1 | 1997-12-16 |
Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them
Grant 5,364,868 - Englert , et al. November 15, 1 | 1994-11-15 |
Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
Grant 5,236,943 - Heitsch , et al. August 17, 1 | 1993-08-17 |
Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
Grant 5,231,083 - Linz , et al. July 27, 1 | 1993-07-27 |
Benzoylguanidines, a process for their preparation, their use as medicaments and medicaments containing them
Grant 5,091,394 - Englert , et al. February 25, 1 | 1992-02-25 |
| 